Upperton Pharma Solutions Wins Business Expansion Award at the 2025 Pharmaceutical Technology Excellence Awards.
Upperton Pharma Solutions (Upperton) Wins Integrated Manufacturing Award at the 2025 Pharmaceutical Technology Excellence Awards.
- Upperton, UK-based CDMO (Contract, Development & Manufacturing Organisation) recognised as winner in the Integrated Manufacturing (Business Expansion) category at the 2025 Pharmaceutical Technology Excellence Awards.
- Award follows the build of a 50,000 sq. ft development and manufacturing facility for oral, nasal and pulmonary dosage forms, alongside a 7,000 sq. ft sterile manufacturing facility built against revised EU GMP Annex-1 regulations.
- CEO, Nikki Whitfield said: “Being recognised as an Excellence Award winner is a great achievement and highlights the hard work of all of our team over the past few years. This award recognises the vision we had when embarking on a new facility, and expansion into sterile manufacturing”.
To read the full article, visit: https://upperton.com/upperton-pharma-solutions-wins-business-expansion-award-at-the-2025-pharmaceutical-technology-excellence-awards/
Related News